Genetic Analysis AS (XSAT:GEAN)
0.8000
+0.0250 (3.23%)
At close: Dec 3, 2025
Genetic Analysis AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 17.74 | 13.37 | 16.29 | 25.32 | 46.81 | 24.19 | Upgrade |
Cash & Short-Term Investments | 17.74 | 13.37 | 16.29 | 25.32 | 46.81 | 24.19 | Upgrade |
Cash Growth | 55.60% | -17.92% | -35.66% | -45.90% | 93.48% | 502.76% | Upgrade |
Accounts Receivable | 1.04 | 3.2 | 1.9 | 2.61 | 1.05 | 0.86 | Upgrade |
Other Receivables | 3.56 | 4.16 | 9.15 | 4.99 | 6.95 | 0.73 | Upgrade |
Receivables | 4.6 | 7.35 | 11.04 | 7.6 | 8 | 1.59 | Upgrade |
Inventory | 0.38 | 0.76 | 1.54 | 1.75 | 2.37 | 1.89 | Upgrade |
Prepaid Expenses | - | 0.21 | 0.18 | 0.76 | 0.42 | 0.34 | Upgrade |
Other Current Assets | 0 | -0 | - | - | - | - | Upgrade |
Total Current Assets | 22.72 | 21.7 | 29.06 | 35.44 | 57.6 | 28.01 | Upgrade |
Property, Plant & Equipment | 4.43 | 5.02 | 6.19 | 8.14 | 1.59 | 1.62 | Upgrade |
Long-Term Investments | -0.05 | -0.05 | 0.41 | - | - | - | Upgrade |
Other Intangible Assets | 16.75 | 1.91 | 0.58 | 0.15 | 0.16 | 0.17 | Upgrade |
Long-Term Deferred Charges | - | 13.8 | 17.25 | 20.7 | 24.15 | 25.82 | Upgrade |
Other Long-Term Assets | 0 | - | - | - | -0 | - | Upgrade |
Total Assets | 43.85 | 42.38 | 53.49 | 64.42 | 83.49 | 55.62 | Upgrade |
Accounts Payable | 1.71 | 4.68 | 5.59 | 4.62 | 2.41 | 1.74 | Upgrade |
Accrued Expenses | - | 5.33 | 8.49 | 6.55 | 6.05 | 4.35 | Upgrade |
Current Portion of Long-Term Debt | - | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | Upgrade |
Current Portion of Leases | - | 1.53 | 1.57 | 1.38 | 1.1 | 1.06 | Upgrade |
Current Unearned Revenue | - | - | - | - | - | 0.05 | Upgrade |
Other Current Liabilities | 5.54 | - | - | -0 | - | - | Upgrade |
Total Current Liabilities | 7.25 | 11.84 | 16.05 | 12.95 | 9.97 | 7.59 | Upgrade |
Long-Term Debt | 4.18 | 4.4 | 0.3 | 0.7 | 1.1 | 1.1 | Upgrade |
Long-Term Leases | 2.88 | 3.64 | 5.15 | 6.64 | 0.33 | 0.3 | Upgrade |
Other Long-Term Liabilities | - | -0 | -0 | 0 | - | - | Upgrade |
Total Liabilities | 14.31 | 19.88 | 21.49 | 20.28 | 11.4 | 9 | Upgrade |
Common Stock | 41.45 | 29.63 | 22.92 | 14.95 | 14.95 | 10.3 | Upgrade |
Additional Paid-In Capital | 11.68 | 7.63 | 5.95 | 29.19 | 57.14 | 36.32 | Upgrade |
Retained Earnings | -23.59 | -14.77 | - | - | - | - | Upgrade |
Comprehensive Income & Other | 0 | 0 | 3.13 | - | 0 | - | Upgrade |
Shareholders' Equity | 29.54 | 22.49 | 32 | 44.14 | 72.09 | 46.62 | Upgrade |
Total Liabilities & Equity | 43.85 | 42.38 | 53.49 | 64.42 | 83.49 | 55.62 | Upgrade |
Total Debt | 7.06 | 9.87 | 7.42 | 9.12 | 2.93 | 2.86 | Upgrade |
Net Cash (Debt) | 10.69 | 3.5 | 8.87 | 16.2 | 43.88 | 21.33 | Upgrade |
Net Cash Growth | 314.19% | -60.58% | -45.23% | -63.08% | 105.71% | - | Upgrade |
Net Cash Per Share | 0.18 | 0.08 | 0.34 | 0.65 | 1.75 | 1.24 | Upgrade |
Filing Date Shares Outstanding | 69.09 | 49.38 | 38.2 | 24.92 | 24.92 | 17.17 | Upgrade |
Total Common Shares Outstanding | 69.09 | 49.38 | 38.2 | 24.92 | 24.92 | 17.17 | Upgrade |
Working Capital | 15.47 | 9.86 | 13.01 | 22.49 | 47.63 | 20.42 | Upgrade |
Book Value Per Share | 0.43 | 0.46 | 0.84 | 1.77 | 2.89 | 2.72 | Upgrade |
Tangible Book Value | 12.79 | 20.59 | 31.42 | 43.99 | 71.93 | 46.45 | Upgrade |
Tangible Book Value Per Share | 0.19 | 0.42 | 0.82 | 1.77 | 2.89 | 2.71 | Upgrade |
Machinery | - | 3.79 | 3.33 | 3.21 | 3.25 | 3.17 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.